Vivos Therapeutics (VVOS) Other Accumulated Expenses (2022 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Other Accumulated Expenses of $150000.0 for Q1 2026, down 77.68% year-over-year from $672000.0 in Q1 2025, and down 14.29% quarter-over-quarter from $175000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Other Accumulated Expenses for 5 consecutive years, with $150000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 77.68% year-over-year to $150000.0; the TTM figure through Mar 2026 stood at $150000.0 (down 77.68% YoY), while the FY2025 annual figure was $175000.0, up 75.0% from the prior year.
- Other Accumulated Expenses slipped to $150000.0 in Q1 2026 per VVOS's latest filing, from $175000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $1.0 million in Q2 2025 and bottomed at $100000.0 in Q4 2024.
- Historically, Other Accumulated Expenses has averaged $327625.0 across 5 years, with a median of $198500.0 in 2023.
- Annual changes were most pronounced in 2025 — Other Accumulated Expenses surged 572.19% — and 2026, when it sank 77.68%.
- Vivos Therapeutics' Other Accumulated Expenses stood at $145000.0 in 2022, then soared by 36.55% to $198000.0 in 2023, then plunged by 49.49% to $100000.0 in 2024, then jumped by 75.0% to $175000.0 in 2025, then decreased by 14.29% to $150000.0 in 2026.
- Business Quant data shows VVOS's Other Accumulated Expenses at $150000.0 in Q1 2026, $175000.0 in Q4 2025, and $987000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Dec 31, 2025 | 175,000.00 |
| Sep 30, 2025 | 987,000.00 |
| Jun 30, 2025 | 1.02 Mn |
| Mar 31, 2025 | 672,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 199,000.00 |
| Jun 30, 2024 | 151,000.00 |
| Mar 31, 2024 | 224,000.00 |
| Dec 31, 2023 | 198,000.00 |
| Sep 30, 2023 | 284,000.00 |
| Jun 30, 2023 | 160,000.00 |
| Mar 31, 2023 | 127,000.00 |
| Dec 31, 2022 | 145,000.00 |
| Sep 30, 2022 | 294,000.00 |
| Jun 30, 2022 | 361,000.00 |